about
mission / vision
our team
board members
executive leadership
scientists
careers
postdoctoral programs
internship programs
current job opportunities
| |
 |
Mark Orr, PhD
Scientist I
Mark Orr is a Scientist I at IDRI. Mark works with the TB Vaccine Development group, where he is focused on developing next generation TB vaccines and understanding the critical components of the immune response to Mycobacterium tuberculosis.
Mark received his PhD from the Department of Immunology at the University of Washington. His thesis work with Dr. Chris Wilson was focused on the immune evasion strategies employed by herpes simplex virus. Mark did his postdoctoral work with Dr. Lewis Lanier at the University of California, San Francisco, where he focused on the response of natural killer (NK) cells to viral infection, studying both the signaling pathways and educational programs that shape NK cell responses to infection in vivo.
|
|
